2023
Implementation of a Best Practice Advisory to Improve Infection Screening Prior to New Prescriptions of Biologics and Targeted Synthetic Drugs
Baker H, Fine R, Suter F, Allore H, Hsiao B, Chowdhary V, Lavelle E, Chen P, Hintz R, Suter L, Danve A. Implementation of a Best Practice Advisory to Improve Infection Screening Prior to New Prescriptions of Biologics and Targeted Synthetic Drugs. Arthritis Care & Research 2023 PMID: 37382043, DOI: 10.1002/acr.25181.Peer-Reviewed Original ResearchBest practice advisoryHepatitis B virusAutoimmune rheumatic diseasesBPA implementationSynthetic disease-modifying antirheumatic drugsDisease-modifying antirheumatic drugsHepatitis C virus infectionHepatitis B surface antigenC virus infectionUse of biologicsB surface antigenQuality improvement initiativesElectronic health recordsEligible patientsAntirheumatic drugsRheumatic diseasesRheumatology practiceSociety guidelinesB virusPractice advisoryComputerized decision support systemVirus infectionRoutine screeningPatient screeningPatients
2018
TD-08 High type I interferon activity is associated with active class III/IV lupus nephritis in european-american lupus patients independent of anti-dsDNA antibodies
Iwamoto T, Dorschner J, Jensen M, Vsetecka D, Amin S, Makol A, Ernste F, Osborn T, Moder K, Chowdhary V, Niewold T. TD-08 High type I interferon activity is associated with active class III/IV lupus nephritis in european-american lupus patients independent of anti-dsDNA antibodies. 2018, a75.2-a76. DOI: 10.1136/lupus-2018-lsm.127.Peer-Reviewed Original ResearchPS1:1 High type i interferon activity is associated with active class 3/4 lupus nephritis in european-american lupus patients independent of anti-dsdna antibodies
Iwamoto T, Dorschner J, Jensen M, Vsetecka D, Amin S, Makol A, Ernste F, Osborn T, Moder K, Chowdhary V, Niewold T. PS1:1 High type i interferon activity is associated with active class 3/4 lupus nephritis in european-american lupus patients independent of anti-dsdna antibodies. 2018, a32.1-a32. DOI: 10.1136/lupus-2018-abstract.50.Peer-Reviewed Original Research
2016
GG-06 Single cell gene expression studies in lupus patient monocytes reveal novel patterns reflecting disease activity, interferon, and medical treatment
Jin Z, Fan W, Jensen M, Dorschner J, Vsetecka D, Amin S, Makol A, Ernste F, Osborn T, Moder K, Chowdhary V, Niewold T. GG-06 Single cell gene expression studies in lupus patient monocytes reveal novel patterns reflecting disease activity, interferon, and medical treatment. Lupus Science & Medicine 2016, 3: a30. DOI: 10.1136/lupus-2016-000179.58.Peer-Reviewed Original ResearchNon-classical monocytesSLE patientsDisease activityClassical monocytesPatients' monocytesCell gene expressionAnti-dsDNA titersHigh disease activityHigher IFN scoresSLE patient groupAnti-inflammatory genesMonocyte gene expressionPrednisone useGene expressionMedication useClinical featuresInterferon signatureC3 complementIFN scorePatient groupImmunologic characteristicsUnsupervised hierarchical clusteringMedical treatmentPatientsIncidence of systemic lupus erythematosus in a population-based cohort using revised 1997 American College of Rheumatology and the 2012 Systemic Lupus International Collaborating Clinics classification criteria
Ungprasert P, Sagar V, Crowson C, Amin S, Makol A, Ernste F, Osborn T, Moder K, Niewold T, Maradit-Kremers H, Ramsey-Goldman R, Chowdhary V. Incidence of systemic lupus erythematosus in a population-based cohort using revised 1997 American College of Rheumatology and the 2012 Systemic Lupus International Collaborating Clinics classification criteria. Lupus 2016, 26: 240-247. PMID: 27365370, PMCID: PMC5201452, DOI: 10.1177/0961203316657434.Peer-Reviewed Original ResearchConceptsSystemic lupus erythematosusACR-97SLICC-12Lupus erythematosusSystemic Lupus International Collaborating Clinics classification criteriaSystemic Lupus International Collaborating Clinics (SLICC) groupClassification criteriaIncidence of lupusIncident SLE patientsRenal-limited diseaseSLICC-12 criteriaRochester Epidemiology ProjectACR classification criteriaPopulation-based cohortOlmsted CountyMedian durationSLE patientsAdjusted incidenceAmerican CollegeClinic groupHigh incidenceImmunologic criteriaNeurologic criteriaPatientsIncidence
2013
CT angiographic imaging characteristics of thoracic idiopathic aortitis
Chowdhary VR, Crowson CS, Bhagra AS, Warrington KJ, Vrtiska TJ. CT angiographic imaging characteristics of thoracic idiopathic aortitis. Journal Of Cardiovascular Computed Tomography 2013, 7: 297-302. PMID: 24268116, DOI: 10.1016/j.jcct.2013.08.009.Peer-Reviewed Original ResearchMeSH KeywordsAgedAged, 80 and overAorta, ThoracicAortic Aneurysm, ThoracicAortitisAortographyAtherosclerosisDiabetes MellitusFemaleHumansHyperlipidemiasHypertensionMaleMiddle AgedPredictive Value of TestsPrevalenceRetrospective StudiesRisk FactorsSmokingTomography, X-Ray ComputedVascular CalcificationConceptsAtherosclerotic risk factorsControl group IIdiopathic aortitisControl group IIRisk factorsThoracic aortaGroup IIGroup IAortic diameterTraditional atherosclerotic risk factorsRetrospective case-control studyPrevalence of hypertensionCT angiographic findingsCase-control studyCT angiographic imagesLymphoplasmacytic inflammationAngiographic findingsCalcification scoreCurrent smokingDiffuse dilatationPathology databaseSecondary causesIA casesPatientsCase records
2002
Outcome in juvenile dermatomyositis.
Chowdhary V, Wakhlu A, Agarwal A, Misra R. Outcome in juvenile dermatomyositis. Indian Pediatrics 2002, 39: 931-5. PMID: 12428038.Peer-Reviewed Original ResearchConceptsJuvenile dermatomyositisComplete remissionMuscle involvementMuscle weaknessNeck muscle weaknessPharyngeal muscle involvementRespiratory muscle involvementTertiary care hospitalProximal muscle weaknessInterstitial lung diseaseGI bleedHeliotrope rashPartial remissionMedian durationCare hospitalMedian ageClinical featuresPyogenic infectionsLung diseaseRetrospective analysisPatientsCase recordsDermatomyositisRemissionComplicationsMultifocal Tubercular Dactylitis in an Adult
Chowdhary V, Aggarwal A, Misra R. Multifocal Tubercular Dactylitis in an Adult. JCR Journal Of Clinical Rheumatology 2002, 8: 35-37. PMID: 17039198, DOI: 10.1097/00124743-200202000-00008.Peer-Reviewed Original ResearchImmunosuppressive treatmentPoncet's diseaseTubercular dactylitisSkeletal tuberculosisHIV infectionMusculoskeletal tuberculosisRare manifestationBetter prognosisPulmonary lesionsRisk factorsAppropriate drugsDactylitisTuberculosisComplete recoveryDiseaseWidespread diseaseTreatmentMultiple manifestationsManifestationsSpondylitisPatientsPrognosisLesionsInfectionMonths
2000
Sweet's syndrome and Pneumocystis carinii pneumonia: two sequelae of low‐dose cytosine arabinoside therapy in a patient with acute myeloid leukemia
Chowdhary V, Nityanand S, Prasad K, Pandey R, Dabadghao S. Sweet's syndrome and Pneumocystis carinii pneumonia: two sequelae of low‐dose cytosine arabinoside therapy in a patient with acute myeloid leukemia. European Journal Of Haematology 2000, 65: 72-73. PMID: 10914942, DOI: 10.1034/j.1600-0609.2000.9c177.x.Peer-Reviewed Original ResearchConceptsAcute myeloid leukemiaPneumocystis carinii pneumoniaMyeloid leukemiaCarinii pneumoniaLow‐dose cytosine arabinoside therapyAcute febrile neutrophilic dermatosisAttainment of remissionFebrile neutrophilic dermatosisLow-dose cytosineNeutrophilic dermatosisSweet's syndromeImmunosuppressive potentialNeutrophil functionLow doseLow dosesLeukemiaPneumoniaSyndromeDirect effectRemissionSequelaePatientsDermatosesTherapyDose